Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Thalla

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Experimental Hematology & Oncology|June 18, 2025
Advances and challenges in the treatment of myelodysplastic syndromesRohit Thalla, Ryan Mack, Jorgena Kosti-Schwartz, et al.
STAR Protocols|May 31, 2022
Murine brain tumor microenvironment immunophenotyping using mass cytometryBrandon L McClellan, Mahmoud S Alghamri, Rohit Thalla, et al.
Neuro-Oncology Advances|July 10, 2020
Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1Mahmoud S Alghamri, Rohit Thalla, Ruthvik P Avvari, et al.
Haematologica|October 30, 2025
TGFβ-activated kinase-1 knockdown in hematopoietic stem-progenitor cells causes PANoptosis and myelodysplastic syndrome-like disease in miceLei Zhang, Wenyan Li, Rohit Thalla, et al.
Frontiers in Pharmacology|June 4, 2021
Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical DevelopmentsMahmoud S Alghamri, Brandon L McClellan, Carson S Hartlage, et al.
Science Advances|September 29, 2021
G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapyMahmoud S Alghamri, Brandon L McClellan, Ruthvik P Avvari, et al.
ACS Nano|May 26, 2022
Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma ImmunotherapyMahmoud S Alghamri, Kaushik Banerjee, Anzar A Mujeeb, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Experimental Hematology & Oncology|June 18, 2025
Advances and challenges in the treatment of myelodysplastic syndromesRohit Thalla, Ryan Mack, Jorgena Kosti-Schwartz, et al.
STAR Protocols|May 31, 2022
Murine brain tumor microenvironment immunophenotyping using mass cytometryBrandon L McClellan, Mahmoud S Alghamri, Rohit Thalla, et al.
Neuro-Oncology Advances|July 10, 2020
Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1Mahmoud S Alghamri, Rohit Thalla, Ruthvik P Avvari, et al.
Haematologica|October 30, 2025
TGFβ-activated kinase-1 knockdown in hematopoietic stem-progenitor cells causes PANoptosis and myelodysplastic syndrome-like disease in miceLei Zhang, Wenyan Li, Rohit Thalla, et al.
Frontiers in Pharmacology|June 4, 2021
Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical DevelopmentsMahmoud S Alghamri, Brandon L McClellan, Carson S Hartlage, et al.
Science Advances|September 29, 2021
G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapyMahmoud S Alghamri, Brandon L McClellan, Ruthvik P Avvari, et al.
ACS Nano|May 26, 2022
Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma ImmunotherapyMahmoud S Alghamri, Kaushik Banerjee, Anzar A Mujeeb, et al.
Pageof 1